1-15 of 15
Dana Yehudai-Ofir
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparable Outcomes of Point-of-Care and Commercial CD19 CAR-T Therapies: A Patient-Matched Analysis in Large B-Cell Lymphoma

Ronit Marcus, Abraham Avigdor, Uri Greenbaum, Noa Golan Accav, Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Elad Jacoby, Arnon Nagler, Avichai Shimoni, Annamaria Ballweg, Xavier Deschênes-Simard, Efrat Luttwak, Gunjan L. Shah, Michael Scordo, Parastoo B Dahi, Miguel Angel Perales, Tsila Zuckerman, Israel Henig, Dana Yehudai-Ofir, Hazim Khatib, Roni Shouval, Ofrat Beyar Katz
Journal: Blood
Blood (2024) 144 (Supplement 1): 608.
https://doi.org/10.1182/blood-2024-207638
Published: 2024
Journal Articles

Reduction in Platelet Counts May Predict the Development of Immune Effector Cell Associated Neurotoxicity Syndrome in Patients Receiving CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma

Hazim Khatib, Amit Parizat, Jabour Halloun, Roni Shouval, Niveen Shibli, Onit Alalouf, Tsila Zuckerman, Nataly Vahaba, Iris Halamish, Danielle Sapir, Israel Henig, Dana Yehudai-Ofir, Shimrit Harlev, Netanel A. Horowitz, Noa Lavi, Nurit Horesh, Riva Fineman, Inna Tzoran, Tsofia Levi, Eldad J. Dann, Ahmad Mruwat, Benjamin Brenner, Ron Hoffman, Ayal Rozenberg, Yoav Shechtman, Ofrat Beyar-Katz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1748.
https://doi.org/10.1182/blood-2024-202937
Published: 2024
Journal Articles

For Patients with Adverse-Risk Acute Myeloid Leukemia, Frontline FLAG Ida with Venetoclax Is Safe and Efficacious

Baher Krayem, Avraham Frisch, Tsila Zuckerman, Israel Henig, Dana Yehudai-Ofir, Boaz Nachmias, Hazim Khatib, Arnon Haran, Shlomzion Aumann
Journal: Blood
Blood (2024) 144 (Supplement 1): 4269.
https://doi.org/10.1182/blood-2024-204627
Published: 2024
Journal Articles

The Ability of Currently Used Scoring Systems to Predict 30 and 100-Days Non-Relapse Mortality Among Older Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Amir Tafesh, Dana Yehudai-Ofir, Ofrat Beyar-Katz, Hazim Khatib, Baher Krayem, Avraham Frisch, Tsila Zuckerman, Israel Henig
Journal: Blood
Blood (2024) 144 (Supplement 1): 3482.
https://doi.org/10.1182/blood-2024-194308
Published: 2024
Journal Articles

Belumosudil Is Efficacious for the Management of Heavily Pretreated and Prolonged Chronic Graft-Versus-Host Disease: A Retrospective Multi-Center Real-World Study By the Israel Association for Bone Marrow Transplantation and Cellular Therapy

Ben Varon, Ron Ram, Avichai Shimoni, Batia Avni, Sigal Grisariu, Vered Stavi, Yael Bar-On, Moshe Yeshurun, Ronit Elhasid, Aharon Gefen, Asaf Yanir, Odelia Amit, Dana Yehudai-Ofir, Israel Henig, Tsila Zuckerman
Journal: Blood
Blood (2024) 144 (Supplement 1): 7338.
https://doi.org/10.1182/blood-2024-206874
Published: 2024
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan -Fludarabine and Busulfan-Fludarabine Conditioning Have Similar Efficacy in Patients ≥65 Years Old or Those with Comorbidities

Israel J. Henig, Ohad Geller, Dana Yehudai-Ofir, Baher Krayem, Avraham Frisch, Hazim Khatib, Tsila Zuckerman
Journal: Blood
Blood (2023) 142 (Supplement 1): 2166.
https://doi.org/10.1182/blood-2023-180721
Published: 2023
Journal Articles

Soluble LAG3: A Potential Marker for the Development and Activity of Acute Graft-Versus-Host Disease

Dana Yehudai-Ofir, Nasren Eiza, Israel J. Henig, Tsila Zuckerman, Zahava Vadasz
Journal: Blood
Blood (2023) 142 (Supplement 1): 4795.
https://doi.org/10.1182/blood-2023-184496
Published: 2023
Journal Articles

Letermovir Prophylaxis for High-Risk Allogenic Transplantation Recipients, Real- World Israeli Experience

Sigal Grisariu Greenzaid, Ron Ram, Mona Kazuli, Dana Yehudai-Ofir, Liat Shargian, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Yael Bar-On, Eran Zimran, Adir Shaulov, Polina Stepensky, Jacob Strahilevitz, Batia Avni
Journal: Blood
Blood (2022) 140 (Supplement 1): 12833–12834.
https://doi.org/10.1182/blood-2022-164694
Published: 2022
Journal Articles

Response Rates of Extra-Nodal Diffuse Large B Cell Lymphoma to CD19-CAR T Cells - a Real Word Retrospective Multi-Center Study

Ofrat Beyar Katz, Chava Perry, Efrat Luttwak, Inbal Sdayoor, Yael Bar-On, Odelia Amit, Ronit Gold, Yair Herishanu, Noam Benyamini, Sigal Grisariu Greenzaid, Batia Avni, Polina Stepensky, Diana Libster, Dana Yehudai-Ofir, Shimrit Harlev, Liat Sharvit, Tsila Zuckerman, Uri Greenbaum, Irit Avivi, Ron Ram
Journal: Blood
Blood (2022) 140 (Supplement 1): 3816–3817.
https://doi.org/10.1182/blood-2022-165149
Published: 2022
Journal Articles

A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study

Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Dana Yehudai-Ofir, Irit Avivi, Orit Gutfeld, Polina Stepensky, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Batia Avni, Ronit Gurion, Yael Bar-On, Ofrat Beyar-Katz, Ronit Gold, Shimrit Ringelstein, Itai Levi, Tzvi Porges, Chava Perry
Journal: Blood
Blood (2021) 138 (Supplement 1): 1733.
https://doi.org/10.1182/blood-2021-151085
Published: 2021
Journal Articles

Safety and Preliminary GvHD Mitigation in First in Human Clinical Trial of Apograft in Match Related Stem Cell Transplantation (SCT)

Tsila Zuckerman, Polina Stepensky, Dana Yehudai-Ofir, Israel Henig, Moshe Kamar, Jerry Stein
Journal: Blood
Blood (2021) 138 (Supplement 1): 2893.
https://doi.org/10.1182/blood-2021-149419
Published: 2021
Journal Articles

Omitting Fluoroquinolones Antibiotic Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Increase Gram-Negative Bacteremia Rate or Transplant-Related Mortality

Israel Henig, MD, Oryan Henig, Haggai Bar-Yoseph, Hanin Daoud, Dana Yehudai-Ofir, MD, Ilana Oren, Tsila Zuckerman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-142357
Published: 2020
Journal Articles

NPM1 Quantitative Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia Allows More Precise Selection of Patients for Allogeneic Stem Cell Transplantation without Affecting Their Survival

Yishai Ofran, MD, Ronit Leiba, Dina Rosenberg, Israel Henig, MD, Dana Yehudai-Ofir, MD, Nuhad Haddad, MD, Riva Fineman, MD, Avraham Frisch, MD, Doaa Okasha, MD, Yariv Carasso, MD, Tsila Zuckerman, MD, Nurit Horesh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2603.
https://doi.org/10.1182/blood-2019-126553
Published: 2019
Journal Articles

Radiation-Free Protocol for Patients with Acute Lymphoblastic Leukemia and Mixed Phenotype Acute Leukemia Undergoing Induction Chemotherapy and Allogeneic Hematopoietic Cell Transplantation - a Multicenter Historical Prospective Study

Odelia Amit, MD, Yael Bar-On, MD, Irit Avivi, Tsila Zuckerman, MD, Galit Perets, MD, Israel Henig, MD, Itai Levi, MD, Dana Yehudai-Ofir, MD, Shimrit Ringelstein Harlev, MD, Ron Ram, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5654.
https://doi.org/10.1182/blood-2019-128248
Published: 2019
Journal Articles

The Thymidine Dideoxynucleoside Analogue, Alovudine, Inhibits the Mitochondrial DNA Polyermase, POLG, Impairs Oxidative Phosphorylation and Promotes Monocytic Differentiation in AML

Dana Yehudai-Ofir, MD, Sanduni U. Liyanage, Hon. B. Sc, PhD, Rose Hurren, BSc, Marcela Gronda, MSc, Danny V. Jeyaraju, PhD, Xiaoming Wang, Thirushi Siriwardena, Yulia Jitkova, PhD, Aaron D. Schimmer, MDPhD, Biljana Rizoska, PhD, Paul Targett-Adams, PhD, Mark Albertella, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2524.
https://doi.org/10.1182/blood.V130.Suppl_1.2524.2524
Published: 2017